<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="pmc-domain-id">1754</journal-id><journal-id journal-id-type="pmc-domain">frontimmu</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10192729</article-id><article-id pub-id-type="pmcid-ver">PMC10192729.1</article-id><article-id pub-id-type="pmcaid">10192729</article-id><article-id pub-id-type="pmcaiid">10192729</article-id><article-id pub-id-type="pmid">37215102</article-id><article-id pub-id-type="doi">10.3389/fimmu.2023.1167021</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Mini Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Sex-biased immunological processes drive hidradenitis suppurativa</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Young</surname><given-names initials="KZ">Kelly Z.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dimitrion</surname><given-names initials="P">Peter</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhou</surname><given-names initials="L">Li</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/927024"/></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Adrianto</surname><given-names initials="I">Indra</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref><xref rid="fn001" ref-type="author-notes">
<sup>*</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/944898"/></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Mi</surname><given-names initials="QS">Qing-Sheng</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref><xref rid="fn001" ref-type="author-notes">
<sup>*</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/475516"/></contrib></contrib-group><aff id="aff1">
<sup>1</sup>
<institution>Center for Cutaneous Biology and Immunology Research, Department of Dermatology, Henry Ford Health</institution>, <addr-line>Detroit, MI</addr-line>, <country>United States</country>
</aff><aff id="aff2">
<sup>2</sup>
<institution>University of Michigan Medical School</institution>, <addr-line>Ann Arbor, MI</addr-line>, <country>United States</country>
</aff><aff id="aff3">
<sup>3</sup>
<institution>Immunology Research Program, Henry Ford Cancer Institute, Henry Ford Health</institution>, <addr-line>Detroit, MI</addr-line>, <country>United States</country>
</aff><aff id="aff4">
<sup>4</sup>
<institution>Cancer Biology Graduate Program, School of Medicine, Wayne State University</institution>, <addr-line>Detroit, MI</addr-line>, <country>United States</country>
</aff><aff id="aff5">
<sup>5</sup>
<institution>Department of Medicine, College of Human Medicine, Michigan State University</institution>, <addr-line>East Lansing, MI</addr-line>, <country>United States</country>
</aff><aff id="aff6">
<sup>6</sup>
<institution>Center for Bioinformatics, Department of Public Health Sciences, Henry Ford Health</institution>, <addr-line>Detroit, MI</addr-line>, <country>United States</country>
</aff><author-notes><fn fn-type="edited-by"><p>Edited by: James Cheng-Chung Wei, Chung Shan Medical University Hospital, Taiwan</p></fn><fn fn-type="edited-by"><p>Reviewed by: Georgios Nikolakis, Dessau Medical Center, Germany; Shuo-Yan Gau, Chung Shan Medical University, Taiwan</p></fn><corresp id="fn001">*Correspondence: Qing-Sheng Mi, <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mailto:qmi1@hfhs.org">qmi1@hfhs.org</email>; Indra Adrianto, <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mailto:iadrian1@hfhs.org">iadrian1@hfhs.org</email></corresp></author-notes><pub-date pub-type="epub"><day>04</day><month>5</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>14</volume><issue-id pub-id-type="pmc-issue-id">427662</issue-id><elocation-id>1167021</elocation-id><history><date date-type="received"><day>15</day><month>2</month><year>2023</year></date><date date-type="accepted"><day>13</day><month>4</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>19</day><month>05</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-05-23 11:25:10.623"><day>23</day><month>05</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2023 Young, Dimitrion, Zhou, Adrianto and Mi</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Young, Dimitrion, Zhou, Adrianto and Mi</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fimmu-14-1167021.pdf"/><abstract><p>Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that can manifest with abscesses, sinus tracts, and scarring in the intertriginous areas of the body. HS is characterized by immune dysregulation, featuring elevated levels of myeloid cells, T helper (Th) cells, and pro-inflammatory cytokines, particularly those involved in Th1- and Th17-mediated immunity. In most epidemiological studies, HS shows a strong female sex bias, with reported female-to-male ratios estimated at roughly 3:1, suggesting that sex-related factors contribute to HS pathophysiology. In this article, we review the role of intrinsic and extrinsic factors that contribute to immunological differences between the sexes and postulate their role in the female sex bias observed in HS. We discuss the effects of hormones, X chromosome dosage, genetics, the microbiome, and smoking on sex-related differences in immunity to postulate potential immunological mechanisms in HS pathophysiology. Future studies are required to better characterize sex-biased factors that contribute to HS disease presentations.</p></abstract><kwd-group><kwd>hidradenitis suppurativa</kwd><kwd>sex</kwd><kwd>immune activation</kwd><kwd>Th17</kwd><kwd>hormones</kwd><kwd>X chromosome</kwd></kwd-group><funding-group><funding-statement>This work was supported by the following grants: R01AR078688, R21AR079089, R33AR076803 to IA and Q-SM from the NIAMS/NIH; Henry Ford Immunology Program Research Support to IA, LZ, and Q-SM; T32-GM007863 to KZY.</funding-statement></funding-group><counts><fig-count count="1"/><table-count count="0"/><equation-count count="0"/><ref-count count="55"/><page-count count="6"/><word-count count="2534"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Inflammation</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><label>1</label><title>Introduction</title><p>Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition clinically characterized by abscesses, sinus tracts, and scarring that commonly affects intertriginous skin (<xref rid="B1" ref-type="bibr">1</xref>). Although thought to be a relatively rare disorder, with reported prevalence rates ranging from 0.00033% to 4.1% (<xref rid="B2" ref-type="bibr">2</xref>), HS carries a significant disease burden, as it is associated with dramatic impairment in patient quality of life and increased rates of health comorbidities (<xref rid="B1" ref-type="bibr">1</xref>). Currently, the mechanisms underlying HS remain unclear, and an improved understanding of disease pathogenesis is imperative for the development of new therapies.</p><p>Patients with HS exhibit marked cutaneous immune dysregulation, featuring elevated levels of innate immune cells, adaptive immune cells, and pro-inflammatory cytokines, particularly those involved in Th1 and Th17 pathways, such as interleukin (IL)17, IL6, IL23, IL1&#946;, IL12, interferon (IFN)-&#947;, IL8, and tumor necrosis factor (TNF)-alpha (<xref rid="f1" ref-type="fig">
<bold>Figure&#160;1</bold>
</xref>) (<xref rid="B3" ref-type="bibr">3</xref>&#8211;<xref rid="B5" ref-type="bibr">5</xref>). The clinical efficacy of cytokine blocking immunotherapy&#8212;such as adalimumab, secukinumab, and brodalumab&#8212;supports a role for inflammatory cytokines as key mediators of disease (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B6" ref-type="bibr">6</xref>&#8211;<xref rid="B9" ref-type="bibr">9</xref>). For example, brodalumab, which is a monoclonal antibody that inhibits IL-17 receptor A, has been shown to reduce the level of circulating cutaneous inflammatory cytokines known to promote neutrophil, T cell, and B cells, mediated inflammatory processes (<xref rid="B10" ref-type="bibr">10</xref>). Additionally, altered levels of antimicrobial peptides (AMPs), which are important elements of innate immunity and potent immunomodulators, are often seen in lesional and nonlesional skin in patients with HS (<xref rid="f1" ref-type="fig">
<bold>Figure&#160;1</bold>
</xref>) (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B11" ref-type="bibr">11</xref>).</p><fig position="float" id="f1" orientation="portrait"><label>Figure&#160;1</label><caption><p>Proposed immunological contributions to the female sex bias in hidradenitis suppurativa. Intrinsic factors (blue semicircle) include genetic, epigenetic, hormonal, and chromosomal contributions to sex-related differences in immunity. Extrinsic factors (yellow semicircle) include contributions from the cutaneous microbiome, gut microbiome, and environmental influences, such as smoking. We propose that these factors affect the Th1 pathway, Th17 pathway, inflammasome activation, and AMP dysregulation in hidradenitis suppurativa.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fimmu-14-1167021-g001.jpg"/></fig><p>Geographic variability is evident in the epidemiologic data on HS, but most studies from North America and Europe report a female-to-male ratio of ~3:1 (<xref rid="B12" ref-type="bibr">12</xref>). This female sex bias is reminiscent of several autoimmune conditions, such as Sj&#246;gren syndrome (SS), systemic sclerosis (SSc), and systemic lupus erythematosus (SLE), which also feature a dramatic female sex bias (<xref rid="B13" ref-type="bibr">13</xref>). Although HS is thought to have more of an autoinflammatory rather than autoimmune component, similar processes may contribute to the female sex bias in HS. Through a review of both intrinsic and extrinsic sex-biased immunological contributions to select autoimmune disorders, we discuss the potential mechanisms that may contribute to the female sex bias observed in HS. Note: In this manuscript, &#8220;sex&#8221; will be used to denote biologic differences in sex chromosomes, hormones, and gonads, while &#8220;gender&#8221; takes into account psychosocial and cultural factors (<xref rid="B12" ref-type="bibr">12</xref>&#8211;<xref rid="B14" ref-type="bibr">14</xref>).</p></sec><sec id="s2"><label>2</label><title>Intrinsic immunologic contributions to the increased prevalence of hidradenitis suppurativa in biologic females</title><p>How biological sex influences the immune system has recently been reviewed by Jiwrajka and Anguera (<xref rid="B14" ref-type="bibr">14</xref>). The idea that biological females exhibit greater thymic output than biological males is becoming increasingly accepted, partially explaining the larger proportion of T cells that comprise the adult female immune system. Females also harbor a greater proportion of B cells, whereas males are known to have greater proportions of natural killer cells and monocytes (<xref rid="B14" ref-type="bibr">14</xref>). Broadly speaking, innate, antigen-specific, and humoral immune responses are more robust in biologic females (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B15" ref-type="bibr">15</xref>), which may be explained by factors intrinsic to females. While antigen specificity has not been defined as a feature of HS, innate and humoral immune responses are clear features of HS (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>), and evidence of the effects of hormones, X-chromosome dosage, and sex-biased genes on immunological pathways highlights potential contributors to the female sex bias in HS.</p><sec id="s2_1"><label>2.1</label><title>Hormones</title><p>Hormonal fluctuations during puberty, the menstrual cycle, pregnancy, and menopause have been associated with the onset of HS and/or HS flares in some patients, highlighting that the effect of sex hormones on the cutaneous immune system may contribute to HS pathogenesis (<xref rid="B18" ref-type="bibr">18</xref>). Hormones regulate immune cell function through nuclear and non-nuclear receptors (<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B19" ref-type="bibr">19</xref>). Studies using animal models have found that females have more robust Th1 adaptive immunity, and naive CD4+ T cells from females proliferate more rapidly and secrete higher levels of IFN-gamma than male T cells (<xref rid="B20" ref-type="bibr">20</xref>). Estrogen has complex, varying effects on the female immune response and has been extensively reviewed elsewhere (<xref rid="B19" ref-type="bibr">19</xref>). This hormone enhances lymphoid cell proliferation, survival, and cytokine expression&#8212;notably IFN-&#947; (<xref rid="B19" ref-type="bibr">19</xref>). At certain concentrations, estrogen can stimulate secretion of IFN-&#947; and promote a Th1 response (<xref rid="B19" ref-type="bibr">19</xref>). Thus, the elevated IFN-&#947; observed in female patients with HS may result, in part, from the effects of estrogen signaling in lymphoid cells, mostly T and natural killer cells (<xref rid="B19" ref-type="bibr">19</xref>).</p><p>Numerous studies have also associated HS with acne, hirsutism, and polycystic ovarian syndrome, supporting a role for androgens on disease (<xref rid="B21" ref-type="bibr">21</xref>). Furthermore, recent case reports have described new-onset and exacerbation of HS symptoms in gender dysphoric patients undergoing supplemental testosterone therapy (<xref rid="B22" ref-type="bibr">22</xref>). Higher proportions of androgen receptor&#8211;positive keratinocytes are found in HS lesional skin relative to healthy skin, and microarray studies indicate enrichment of androgen receptor&#8211;regulated genes in HS lesional skin (<xref rid="B23" ref-type="bibr">23</xref>). Although androgens are generally thought of as having immunosuppressive properties, one potential mechanism contributing to inflammation in HS includes androgen-associated enhancement of Th17 responses resulting in increased IL17 production (<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>). Notably, some patients report clinical improvement with anti-androgen therapy, including spironolactone, finasteride, and antiandrogenic progesterones (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B25" ref-type="bibr">25</xref>). While estrogens and androgens may have opposing function in developmental processes (i.e., sex-determination and puberty), these data highlight that their influence on the immune response is more likely due to combined interactions and relative changes in concentrations leading to immune perturbations.</p><p>Sex hormones also have effects on cutaneous innate immune responses, one of which is activation of the NLRP3 inflammasome (<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B26" ref-type="bibr">26</xref>), which is important for the process of damage-associated molecular pattern (DAMP) and pathogen-associated molecular pattern (PAMP) recognition (<xref rid="B26" ref-type="bibr">26</xref>). The NLRP3 inflammasome activates caspase-1, which leads to the activation of IL1&#946; and IL18 from their pro-peptides, and these molecules have broad effects on downstream immunological activity, such as increasing the expression of chemokines and other inflammatory cytokines (e.g., IL6, TNF-&#945;) (<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>). In certain noncutaneous disorders, androgens have been suggested to directly activate the NLRP3 inflammasome, which provides an interesting hypothesis that may explain the exacerbated HS seen in transgender men who initiate androgenic gender-affirming therapy (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B22" ref-type="bibr">22</xref>). Also, activating mutations in <italic toggle="yes">MEFV</italic>, which encodes the pyrin protein of the pyrin inflammasome, have been found in patients with specific syndromic forms of HS, although syndromic HS typically encompasses additional findings, such as osteoarticular manifestations (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B25" ref-type="bibr">25</xref>&#8211;<xref rid="B27" ref-type="bibr">27</xref>). Several studies have also identified elevated IL1beta and increased NLRP3 expression in skin lesions of patients with HS (<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B29" ref-type="bibr">29</xref>). Furthermore, HS lesions harbor features suggestive of inflammasome activity, including enhanced caspase-1 activity (<xref rid="B28" ref-type="bibr">28</xref>). As such, the NLRP3 inflammasome may play a role in HS, and the effect of sex hormones on NLRP3 activation may further contribute to sex-related differences in HS. As of now, the precise roles for different hormones have not been well placed in HS pathophysiology. Future studies elucidating the effects of sex hormones on inflammasome activation or immune cell function in patients with HS may support a mechanistic link for hormones in the puzzle of HS pathophysiology.</p></sec><sec id="s2_2"><label>2.2</label><title>X chromosome dosage</title><p>Another contributing factor to the female sex bias in autoimmune disorders is X chromosome dosage (<xref rid="B30" ref-type="bibr">30</xref>). Biologic females have two X chromosomes, and one of the X chromosomes undergoes inactivation (X chromosome inactivation; XCI) in early development (<xref rid="B19" ref-type="bibr">19</xref>). Patients with multiple X chromosomes are at increased risk of developing autoimmune disorders, such as SLE and SS, while these disorders have rarely been reported in patients with Turner&#8217;s syndrome, which is an X monosomy (<xref rid="B14" ref-type="bibr">14</xref>). The X chromosome harbors many genes involved in immune function, and XCI is often incomplete, with ~15% of genes escaping inactivation (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B19" ref-type="bibr">19</xref>). Among these are toll-like receptor (TLR)7 and TLR8, which are pattern recognition receptors that principally recognize endosomal single-stranded RNA. Activation of TLR7/8 induces expression of the inflammatory cytokines IL12, IL18, IL27, TNF&#945;, and type I IFNs. Increased expression of TLRs may also contribute to the female sex bias in SLE, SSc, and SS through induction of a type 1 IFN response (<xref rid="B14" ref-type="bibr">14</xref>). Similarly, incomplete XCI and abnormal X chromosome dosage may contribute to the chronic inflammation observed in HS.</p><p>Furthermore, XCI is maintained by Xist/XIST RNA and heterochromatin modifications (e.g., DNA methylation and histone modifications) in immune cells (<xref rid="B14" ref-type="bibr">14</xref>). These processes contribute to the maintenance of appropriate X-linked gene dosage (<xref rid="B14" ref-type="bibr">14</xref>). For example, female-biased hypomethylation of the <italic toggle="yes">CD40LG</italic> promoter in T cells, resulting in greater <italic toggle="yes">CD40LG</italic> expression, is associated with SLE (<xref rid="B14" ref-type="bibr">14</xref>). CD40LG is a surface protein found on CD4+ T cells that binds to CD40 on antigen presenting cells, activating them to initiate a pro-inflammatory immune response (<xref rid="B14" ref-type="bibr">14</xref>). Similar heterochromatic perturbations may influence the expression of sex-biased genes that modulate immunity in patients with HS.</p></sec><sec id="s2_3"><label>2.3</label><title>Other sex-biased genes</title><p>Additionally, there are sex-biased genes involved in immune function that are neither hormonally regulated nor found on the X-chromosome, such as <italic toggle="yes">VGLL3 (</italic>
<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B19" ref-type="bibr">19</xref>
<italic toggle="yes">).</italic> VGLL3 is a transcription cofactor enriched in female skin that activates a gene regulatory network leading to the upregulation of proinflammatory and IFN-response genes (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B31" ref-type="bibr">31</xref>). Genes regulated by VGLL3 in female-predominant autoimmune disorders include B cell-activating factor (upregulated and therapeutically targeted in SLE), MMP9 (SLE, SSc, SS), IL7 (SLE, SS), and ICAM-1 (SLE) (<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B32" ref-type="bibr">32</xref>). It is plausible that additional sex-biased transcription factors or proinflammatory gene modulators involved in autoinflammatory pathways exist and play a role in HS. Additional studies will help to clarify the molecular mechanisms of non-hormone and non-sex chromosome&#8211;related sex-biased gene expression.</p></sec></sec><sec id="s3"><label>3</label><title>Extrinsic immunological contributions to the sex bias in hidradenitis suppurativa</title><sec id="s3_1"><label>3.1</label><title>Microbiome</title><p>Increasing numbers of studies implicate a role for the microbiome in sex-biased immunity (<xref rid="B19" ref-type="bibr">19</xref>). Several studies have identified sex-related alterations in the cutaneous microbiome, which may result from differences between the sexes in hormone metabolism, rates of perspiration, and skin pH (<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B34" ref-type="bibr">34</xref>). For example, sex-related differences in sebum production by the skin and its ability to retain moisture likely contribute to the differing levels of <italic toggle="yes">Cutibacterium</italic> (formerly known as <italic toggle="yes">Propionibacterium)</italic> on the skin of males and females (<xref rid="B34" ref-type="bibr">34</xref>). Notably, the cutaneous microbiome is altered in HS skin versus skin from healthy controls (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B35" ref-type="bibr">35</xref>). Furthermore, differences in the immune system such as those described above may influence the ways in which females respond to changes in the microbiome, which could in turn feedback and influence the microbiome yet further. Although it remains unknown whether sex-related changes in the skin microbiome contribute to HS, dysregulation of the skin microbiome within the context of female-biased immunity may promote Th1 and/or Th17-associated inflammation (<xref rid="B4" ref-type="bibr">4</xref>). Similar to the role of AMPs in the pathogenesis of acne, variation in cutaneous microbes in patients with HS may also directly affect production of AMPs by keratinocytes, contributing to a chronic inflammatory state in HS (<xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B37" ref-type="bibr">37</xref>).</p><p>The gut microbiome is also involved in both innate and adaptive immunity, and sex-related differences have been previously described (<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B38" ref-type="bibr">38</xref>). For instance, sex-related alterations in the gut microbiota have been implicated in Crohn&#8217;s disease pathogenesis (<xref rid="B39" ref-type="bibr">39</xref>). Alterations in the gut microbiome have been reported in other inflammatory skin diseases as well, including psoriasis (<xref rid="B40" ref-type="bibr">40</xref>). Since HS has been consistently linked to diet, obesity, and metabolic syndrome, it is plausible that the gut microbiome influences disease presentation (<xref rid="B41" ref-type="bibr">41</xref>&#8211;<xref rid="B43" ref-type="bibr">43</xref>). Limited small-scale studies have identified changes in gut microbiome composition in patients with HS relative to controls. Larger studies are necessary to establish whether sex-related immunity associated with alterations in the gut microbiome may play a role in HS (<xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B44" ref-type="bibr">44</xref>). Furthermore, additional studies are required to explore the gut-skin axis and determine whether alterations in the gut microbiome may affect the cutaneous inflammation seen in HS.</p></sec><sec id="s3_2"><label>3.2</label><title>Smoking</title><p>In contrast to the dramatic female sex bias in HS revealed in epidemiological studies from North America and Europe, several studies from Asia have shown a male sex bias of ~1:2 (F:M) (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B45" ref-type="bibr">45</xref>&#8211;<xref rid="B47" ref-type="bibr">47</xref>). The opposite trend likely represents a significant role of environmental influences on HS within the context of ancestry-specific genomic features. Smoking is one of the most substantiated environmental risk factors for HS (<xref rid="B42" ref-type="bibr">42</xref>). In a retrospective study conducted in Korea that included 438 patients with HS, the authors reported a higher proportion of male smokers than female smokers (<xref rid="B47" ref-type="bibr">47</xref>). In patients with HS, smoking has been associated with elevated leukocyte and neutrophil levels (<xref rid="B48" ref-type="bibr">48</xref>). Additionally, many chemicals found in tobacco smoke influence aryl hydrocarbon signaling (<xref rid="B49" ref-type="bibr">49</xref>). Recent work identified a potential pathophysiological link between aryl hydrocarbon receptor signaling and chronic inflammatory cutaneous disorders, such as HS (<xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B51" ref-type="bibr">51</xref>). Furthermore, benzopyrene, an aromatic compound found in cigarette smoke, contributes to increased levels of Th17 cells and higher IL17 expression, which are also findings seen in HS (<xref rid="B36" ref-type="bibr">36</xref>). Such changes in the response to cigarette-induced lung inflammation may also inadvertently impact the skin (Dimitrion et&#160;al., under review). In addition to inflammation associated with smoking, chemicals like nicotine, which are structurally related to endogenous molecules like NAD<sup>+</sup>, may perturb skin metabolism (<xref rid="B52" ref-type="bibr">52</xref>). Given recent findings that implicate CD38, an enzyme that degrades NAD+ into nicotinamide, in HS pathogenesis (Dimitrion et&#160;al., under review), future studies examining the downstream signaling pathways influenced by the presence and absence of nicotine may provide additional context into how smoking may directly influence immune cells in patients with HS.</p></sec></sec><sec sec-type="conclusions" id="s4"><label>4</label><title>Conclusion</title><p>HS is a debilitating inflammatory disease that demonstrates a strong female sex bias in numerous studies. The female sex bias in HS is likely multifactorial, with contributions from hormones, genetics, environmental influences, and the microbiome on changes in the immune system. Despite this, many previous studies examining the immunological profiles of patients with HS have not reported stratified results between biologic females and males. Furthermore, sex differences in the response to immunomodulatory HS biologics, such as adalimumab, have not studied (<xref rid="B53" ref-type="bibr">53</xref>, <xref rid="B54" ref-type="bibr">54</xref>). It will be important to consider sex biased efficacy of immunomodulatory drugs in future trials in patients with HS considering the many potential sex-biased immunological contributions to HS. It is also interesting to note that differences in sex-biased immune processes may explain some of the growing literature supporting sex-biased co-morbidities associated with HS. However, in some of the comorbidities, the sex difference was not significant, such as psoriasis (<xref rid="B55" ref-type="bibr">55</xref>). A better understanding of sex-specific effects may also help reframe and improve management of HS in a more effective and equitable manner.</p></sec><sec sec-type="author-contributions" id="s5"><title>Author contributions</title><p>Q-SM and IA conceived and designed the project. KY, Q-SM, and PD performed the literature review and drafted the manuscript. Q-SM, LZ and IA edited the manuscript. All authors contributed to the article and approved the submitted version.</p></sec></body><back><sec sec-type="COI-statement" id="s7"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="disclaimer" id="s8"><title>Publisher&#8217;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naik</surname><given-names>HB</given-names></name><name name-style="western"><surname>Lowes</surname><given-names>MA</given-names></name></person-group>. <article-title>A call to accelerate hidradenitis suppurativa research and improve care-moving beyond burden</article-title>. <source>JAMA Dermatol</source> (<year>2019</year>) <volume>155</volume>(<issue>9</issue>):<page-range>1005&#8211;6</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1001/jamadermatol.2019.1105</pub-id><pub-id pub-id-type="pmcid">PMC9131891</pub-id><pub-id pub-id-type="pmid">31290934</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goldburg</surname><given-names>SR</given-names></name><name name-style="western"><surname>Strober</surname><given-names>BE</given-names></name><name name-style="western"><surname>Payette</surname><given-names>MJ</given-names></name></person-group>. <article-title>Hidradenitis suppurativa: epidemiology, clinical presentation, and pathogenesis</article-title>. <source>J Am Acad Dermatol</source> (<year>2020</year>) <volume>82</volume>(<issue>5</issue>):<page-range>1045&#8211;58</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.jaad.2019.08.090</pub-id><pub-id pub-id-type="pmid">31604104</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>T</given-names></name><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><name name-style="western"><surname>Ying</surname><given-names>S</given-names></name><name name-style="western"><surname>Tang</surname><given-names>S</given-names></name><name name-style="western"><surname>Ding</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>The IL-23/IL-17 pathway in inflammatory skin diseases: from bench to bedside</article-title>. <source>Front Immunol</source> (<year>2020</year>) <volume>11</volume>:<elocation-id>594735</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.3389/fimmu.2020.594735</pub-id><pub-id pub-id-type="pmid">33281823</pub-id><pub-id pub-id-type="pmcid">PMC7705238</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vossen</surname><given-names>ARJV</given-names></name><name name-style="western"><surname>van der Zee</surname><given-names>HH</given-names></name><name name-style="western"><surname>Prens</surname><given-names>EP</given-names></name></person-group>. <article-title>Hidradenitis suppurativa: a systematic review integrating inflammatory pathways into a cohesive pathogenic model</article-title>. <source>Front Immunol</source> (<year>2018</year>) <volume>9</volume>:<elocation-id>2965</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.3389/fimmu.2018.02965</pub-id><pub-id pub-id-type="pmid">30619323</pub-id><pub-id pub-id-type="pmcid">PMC6302105</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomi</surname><given-names>R</given-names></name><name name-style="western"><surname>Cazzaniga</surname><given-names>S</given-names></name><name name-style="western"><surname>Seyed Jafari</surname><given-names>SM</given-names></name><name name-style="western"><surname>Schlapbach</surname><given-names>C</given-names></name><name name-style="western"><surname>Hunger</surname><given-names>RE</given-names></name></person-group>. <article-title>Association of hidradenitis suppurativa with T helper 1/T helper 17 phenotypes: a semantic map analysis</article-title>. <source>JAMA Dermatol</source> (<year>2018</year>) <volume>154</volume>(<issue>5</issue>):<page-range>592&#8211;5</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1001/jamadermatol.2018.0141</pub-id><pub-id pub-id-type="pmcid">PMC6128497</pub-id><pub-id pub-id-type="pmid">29617527</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kjaersgaard Andersen</surname><given-names>R</given-names></name><name name-style="western"><surname>Saunte</surname><given-names>SK</given-names></name><name name-style="western"><surname>Jemec</surname><given-names>GBE</given-names></name><name name-style="western"><surname>Saunte</surname><given-names>DM</given-names></name></person-group>. <article-title>Psoriasis as a comorbidity of hidradenitis suppurativa</article-title>. <source>Int J Dermatol</source> (<year>2020</year>) <volume>59</volume>(<issue>2</issue>):<page-range>216&#8211;20</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/ijd.14651</pub-id><pub-id pub-id-type="pmid">31591714</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tzanetakou</surname><given-names>V</given-names></name><name name-style="western"><surname>Kanni</surname><given-names>T</given-names></name><name name-style="western"><surname>Giatrakou</surname><given-names>S</given-names></name><name name-style="western"><surname>Katoulis</surname><given-names>A</given-names></name><name name-style="western"><surname>Papadavid</surname><given-names>E</given-names></name><name name-style="western"><surname>Netea</surname><given-names>MG</given-names></name><etal/></person-group>. <article-title>Safety and efficacy of anakinra in severe hidradenitis suppurativa: a randomized clinical trial</article-title>. <source>JAMA Dermatol</source> (<year>2016</year>) <volume>152</volume>(<issue>1</issue>):<page-range>52&#8211;9</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1001/jamadermatol.2015.3903</pub-id><pub-id pub-id-type="pmid">26579854</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanni</surname><given-names>T</given-names></name><name name-style="western"><surname>Argyropoulou</surname><given-names>M</given-names></name><name name-style="western"><surname>Spyridopoulos</surname><given-names>T</given-names></name><name name-style="western"><surname>Pistiki</surname><given-names>A</given-names></name><name name-style="western"><surname>Stecher</surname><given-names>M</given-names></name><name name-style="western"><surname>Dinarello</surname><given-names>CA</given-names></name><etal/></person-group>. <article-title>MABp1 targeting IL-1&#945; for moderate to severe hidradenitis suppurativa not eligible for adalimumab: a randomized study</article-title>. <source>J Invest Dermatol</source> (<year>2018</year>) <volume>138</volume>(<issue>4</issue>):<fpage>795</fpage>&#8211;<lpage>801</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.jid.2017.10.030</pub-id><pub-id pub-id-type="pmid">29129600</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vossen</surname><given-names>ARJV</given-names></name><name name-style="western"><surname>van Doorn</surname><given-names>MBA</given-names></name><name name-style="western"><surname>van der Zee</surname><given-names>HH</given-names></name><name name-style="western"><surname>Prens</surname><given-names>EP</given-names></name></person-group>. <article-title>Apremilast for moderate hidradenitis suppurativa: results of a randomized controlled trial</article-title>. <source>J Am Acad Dermatol</source> (<year>2019</year>) <volume>80</volume>(<issue>1</issue>):<page-range>80&#8211;8</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.jaad.2018.06.046</pub-id><pub-id pub-id-type="pmid">30482392</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Navrazhina</surname><given-names>K</given-names></name><name name-style="western"><surname>Frew</surname><given-names>JW</given-names></name><name name-style="western"><surname>Grand</surname><given-names>D</given-names></name><name name-style="western"><surname>Williams</surname><given-names>SC</given-names></name><name name-style="western"><surname>Hur</surname><given-names>H</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Interleukin-17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum</article-title>. <source>Br J Dermatol</source> (<year>2022</year>) <volume>187</volume>(<issue>2</issue>):<page-range>223&#8211;33</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/bjd.21060</pub-id><pub-id pub-id-type="pmcid">PMC9356983</pub-id><pub-id pub-id-type="pmid">35191018</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Frew</surname><given-names>JW</given-names></name><name name-style="western"><surname>Thomsen</surname><given-names>SF</given-names></name><name name-style="western"><surname>Ring</surname><given-names>HC</given-names></name></person-group>. <article-title>Antimicrobial peptides in hidradenitis suppurativa: a systematic review</article-title>. <source>Br J Dermatol</source> (<year>2022</year>) <volume>186</volume>(<issue>2</issue>):<page-range>236&#8211;44</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/bjd.20750</pub-id><pub-id pub-id-type="pmid">34498267</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ingram</surname><given-names>JR</given-names></name></person-group>. <article-title>The epidemiology of hidradenitis suppurativa</article-title>. <source>Br J Dermatol</source> (<year>2020</year>) <volume>183</volume>(<issue>6</issue>):<page-range>990&#8211;8</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/bjd.19435</pub-id><pub-id pub-id-type="pmid">32880911</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xing</surname><given-names>E</given-names></name><name name-style="western"><surname>Billi</surname><given-names>AC</given-names></name><name name-style="western"><surname>Gudjonsson</surname><given-names>JE</given-names></name></person-group>. <article-title>Sex bias and autoimmune diseases</article-title>. <source>J Invest Dermatol</source> (<year>2022</year>) <volume>142</volume>(<issue>3 Pt B</issue>):<page-range>857&#8211;66</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.jid.2021.06.008</pub-id><pub-id pub-id-type="pmid">34362556</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiwrajka</surname><given-names>N</given-names></name><name name-style="western"><surname>Anguera</surname><given-names>MC</given-names></name></person-group>. <article-title>The X in seX-biased immunity and autoimmune rheumatic disease</article-title>. <source>J Exp Med</source> (<year>2022</year>) <volume>219</volume>(<issue>6</issue>):<elocation-id>e20211487</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1084/jem.20211487</pub-id><pub-id pub-id-type="pmid">35510951</pub-id><pub-id pub-id-type="pmcid">PMC9075790</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruggieri</surname><given-names>A</given-names></name><name name-style="western"><surname>Anticoli</surname><given-names>S</given-names></name><name name-style="western"><surname>D&#8217;Ambrosio</surname><given-names>A</given-names></name><name name-style="western"><surname>Giordani</surname><given-names>L</given-names></name><name name-style="western"><surname>Viora</surname><given-names>M</given-names></name></person-group>. <article-title>The influence of sex and gender on immunity, infection and vaccination</article-title>. <source>Ann Ist Super Sanita.</source> (<year>2016</year>) <volume>52</volume>(<issue>2</issue>):<fpage>198</fpage>&#8211;<lpage>204</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.4415/ANN_16_02_11</pub-id><pub-id pub-id-type="pmid">27364394</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gudjonsson</surname><given-names>JE</given-names></name><name name-style="western"><surname>Tsoi</surname><given-names>LC</given-names></name><name name-style="western"><surname>Ma</surname><given-names>F</given-names></name><name name-style="western"><surname>Billi</surname><given-names>AC</given-names></name><name name-style="western"><surname>van Straalen</surname><given-names>KR</given-names></name><name name-style="western"><surname>Vossen</surname><given-names>ARJV</given-names></name><etal/></person-group>. <article-title>Contribution of plasma cells and b cells to hidradenitis suppurativa pathogenesis</article-title>. <source>JCI Insight</source> (<year>2020</year>) <volume>5</volume>(<issue>19</issue>):<elocation-id>e139930</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1172/jci.insight.139930</pub-id><pub-id pub-id-type="pmid">32853177</pub-id><pub-id pub-id-type="pmcid">PMC7566715</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mariottoni</surname><given-names>P</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>SW</given-names></name><name name-style="western"><surname>Prestwood</surname><given-names>CA</given-names></name><name name-style="western"><surname>Jain</surname><given-names>V</given-names></name><name name-style="western"><surname>Suwanpradid</surname><given-names>J</given-names></name><name name-style="western"><surname>Suwanpradid</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Single-cell RNA sequencing reveals cellular and transcriptional changes associated with M1 macrophage polarization in hidradenitis suppurativa</article-title>. <source>Front Med (Lausanne).</source> (<year>2021</year>) <volume>8</volume>:<elocation-id>665873</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.3389/fmed.2021.665873</pub-id><pub-id pub-id-type="pmid">34504848</pub-id><pub-id pub-id-type="pmcid">PMC8421606</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riis</surname><given-names>PT</given-names></name><name name-style="western"><surname>Ring</surname><given-names>HC</given-names></name><name name-style="western"><surname>Themstrup</surname><given-names>L</given-names></name><name name-style="western"><surname>Jemec</surname><given-names>GB</given-names></name></person-group>. <article-title>The role of androgens and estrogens in hidradenitis suppurativa - a systematic review</article-title>. <source>Acta Dermatovenerol Croat.</source> (<year>2016</year>) <volume>24</volume>(<issue>4</issue>):<page-range>239&#8211;49</page-range>.<pub-id pub-id-type="pmid">28128074</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Billi</surname><given-names>AC</given-names></name><name name-style="western"><surname>Kahlenberg</surname><given-names>JM</given-names></name><name name-style="western"><surname>Gudjonsson</surname><given-names>JE</given-names></name></person-group>. <article-title>Sex bias in autoimmunity</article-title>. <source>Curr Opin Rheumatol</source> (<year>2019</year>) <volume>31</volume>(<issue>1</issue>):<fpage>53</fpage>&#8211;<lpage>61</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.1097/BOR.0000000000000564</pub-id><pub-id pub-id-type="pmid">30394940</pub-id><pub-id pub-id-type="pmcid">PMC6296774</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>MA</given-names></name><name name-style="western"><surname>Rego</surname><given-names>D</given-names></name><name name-style="western"><surname>Moshkova</surname><given-names>M</given-names></name><name name-style="western"><surname>Kebir</surname><given-names>H</given-names></name><name name-style="western"><surname>Chruscinski</surname><given-names>A</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Peroxisome proliferator-activated receptor (PPAR)&#945; and -&#947; regulate IFN&#947; and IL-17A production by human T cells in a sex-specific way</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2012</year>) <volume>109</volume>(<issue>24</issue>):<page-range>9505&#8211;10</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1073/pnas.1118458109</pub-id><pub-id pub-id-type="pmcid">PMC3386070</pub-id><pub-id pub-id-type="pmid">22647601</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kozera</surname><given-names>EK</given-names></name><name name-style="western"><surname>Lowes</surname><given-names>MA</given-names></name><name name-style="western"><surname>Hsiao</surname><given-names>JL</given-names></name><name name-style="western"><surname>Frew</surname><given-names>JW</given-names></name></person-group>. <article-title>Clinical considerations in the management of hidradenitis suppurativa in women</article-title>. <source>Int J Womens Dermatol</source> (<year>2021</year>) <volume>7</volume>(<issue>5Part B</issue>):<page-range>664&#8211;71</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.ijwd.2021.10.012</pub-id><pub-id pub-id-type="pmcid">PMC8714605</pub-id><pub-id pub-id-type="pmid">35028361</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buonomo</surname><given-names>M</given-names></name><name name-style="western"><surname>Mansh</surname><given-names>MD</given-names></name><name name-style="western"><surname>Thorpe</surname><given-names>D</given-names></name><name name-style="western"><surname>Goldfarb</surname><given-names>N</given-names></name></person-group>. <article-title>Development or exacerbation of hidradenitis suppurativa in two transgender men after initiation of testosterone therapy</article-title>. <source>Br J Dermatol</source> (<year>2021</year>) <volume>184</volume>(<issue>6</issue>):<page-range>1192&#8211;4</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/bjd.19812</pub-id><pub-id pub-id-type="pmid">33448331</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gratton</surname><given-names>R</given-names></name><name name-style="western"><surname>Del Vecchio</surname><given-names>C</given-names></name><name name-style="western"><surname>Zupin</surname><given-names>L</given-names></name><name name-style="western"><surname>Crovella</surname><given-names>S</given-names></name></person-group>. <article-title>Unraveling the role of sex hormones on keratinocyte functions in human inflammatory skin diseases</article-title>. <source>Int J Mol Sci</source> (<year>2022</year>) <volume>23</volume>(<issue>6</issue>):<elocation-id>3132</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.3390/ijms23063132</pub-id><pub-id pub-id-type="pmid">35328552</pub-id><pub-id pub-id-type="pmcid">PMC8955788</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nikolakis</surname><given-names>G</given-names></name><name name-style="western"><surname>Kyrgidis</surname><given-names>A</given-names></name><name name-style="western"><surname>Zouboulis</surname><given-names>CC</given-names></name></person-group>. <article-title>Is there a role for antiandrogen therapy for hidradenitis suppurativa? a systematic review of published data</article-title>. <source>Am J Clin Dermatol</source> (<year>2019</year>) <volume>20</volume>(<issue>4</issue>):<page-range>503&#8211;13</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s40257-019-00442-w</pub-id><pub-id pub-id-type="pmid">31073704</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zouboulis</surname><given-names>CC</given-names></name><name name-style="western"><surname>Benhadou</surname><given-names>F</given-names></name><name name-style="western"><surname>Byrd</surname><given-names>AS</given-names></name><name name-style="western"><surname>Chandran</surname><given-names>NS</given-names></name><name name-style="western"><surname>Giamarellos-Bourboulis</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Fabbrocini</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>What causes hidradenitis suppurativa?-15 years after</article-title>. <source>Exp Dermatol</source> (<year>2020</year>) <volume>29</volume>(<issue>12</issue>):<page-range>1154&#8211;70</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/exd.14214</pub-id><pub-id pub-id-type="pmid">33058306</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tao</surname><given-names>J</given-names></name></person-group>. <article-title>Sex-related overactivation of NLRP3 inflammasome increases lethality of the Male COVID-19 patients</article-title>. <source>Front Mol Biosci</source> (<year>2021</year>) <volume>8</volume>:<elocation-id>671363</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.3389/fmolb.2021.671363</pub-id><pub-id pub-id-type="pmid">34150848</pub-id><pub-id pub-id-type="pmcid">PMC8212049</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nikolakis</surname><given-names>G</given-names></name><name name-style="western"><surname>Kaleta</surname><given-names>KP</given-names></name><name name-style="western"><surname>Vaiopoulos</surname><given-names>AG</given-names></name><name name-style="western"><surname>Wolter</surname><given-names>K</given-names></name><name name-style="western"><surname>Baroud</surname><given-names>S</given-names></name><name name-style="western"><surname>Wojas-Pelc</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Phenotypes and pathophysiology of syndromic hidradenitis suppurativa: different faces of the same disease? a systematic review</article-title>. <source>Dermatology</source> (<year>2021</year>) <volume>237</volume>(<issue>5</issue>):<page-range>673&#8211;97</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1159/000509873</pub-id><pub-id pub-id-type="pmid">32942279</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lima</surname><given-names>AL</given-names></name><name name-style="western"><surname>Karl</surname><given-names>I</given-names></name><name name-style="western"><surname>Giner</surname><given-names>T</given-names></name><name name-style="western"><surname>Poppe</surname><given-names>H</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>M</given-names></name><name name-style="western"><surname>Presser</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa</article-title>. <source>Br J Dermatol</source> (<year>2016</year>) <volume>174</volume>(<issue>3</issue>):<page-range>514&#8211;21</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/bjd.14214</pub-id><pub-id pub-id-type="pmid">26436522</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de S&#225;</surname><given-names>DC</given-names></name><name name-style="western"><surname>Festa</surname><given-names>C</given-names></name></person-group>. <article-title>Inflammasomes and dermatology</article-title>. <source>Bras Dermatol</source> (<year>2016</year>) <volume>91</volume>(<issue>5</issue>):<page-range>566&#8211;78</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1590/abd1806-4841.20165577</pub-id><pub-id pub-id-type="pmcid">PMC5087212</pub-id><pub-id pub-id-type="pmid">27828627</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guerra-Silveira</surname><given-names>F</given-names></name><name name-style="western"><surname>Abad-Franch</surname><given-names>F</given-names></name></person-group>. <article-title>Sex bias in infectious disease epidemiology: patterns and processes</article-title>. <source>PloS One</source> (<year>2013</year>) <volume>8</volume>(<issue>4</issue>):<elocation-id>e62390</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1371/journal.pone.0062390</pub-id><pub-id pub-id-type="pmid">23638062</pub-id><pub-id pub-id-type="pmcid">PMC3634762</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Billi</surname><given-names>AC</given-names></name><name name-style="western"><surname>Gharaee-Kermani</surname><given-names>M</given-names></name><name name-style="western"><surname>Fullmer</surname><given-names>J</given-names></name><name name-style="western"><surname>Tsoi</surname><given-names>LC</given-names></name><name name-style="western"><surname>Hill</surname><given-names>BD</given-names></name><name name-style="western"><surname>Gruszka</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>The female-biased factor VGLL3 drives cutaneous and systemic autoimmunity</article-title>. <source>JCI Insight</source> (<year>2019</year>) <volume>4</volume>(<issue>8</issue>):<elocation-id>e127291</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1172/jci.insight.127291</pub-id><pub-id pub-id-type="pmid">30996136</pub-id><pub-id pub-id-type="pmcid">PMC6538382</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tsoi</surname><given-names>LC</given-names></name><name name-style="western"><surname>Xing</surname><given-names>X</given-names></name><name name-style="western"><surname>Beamer</surname><given-names>MA</given-names></name><name name-style="western"><surname>Swindell</surname><given-names>WR</given-names></name><name name-style="western"><surname>Sarkar</surname><given-names>MK</given-names></name><etal/></person-group>. <article-title>A gene network regulated by the transcription factor VGLL3 as a promoter of sex-biased autoimmune diseases</article-title>. <source>Nat Immunol</source> (<year>2017</year>) <volume>18</volume>(<issue>2</issue>):<page-range>152&#8211;60</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1038/ni.3643</pub-id><pub-id pub-id-type="pmcid">PMC5289297</pub-id><pub-id pub-id-type="pmid">27992404</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fierer</surname><given-names>N</given-names></name><name name-style="western"><surname>Hamady</surname><given-names>M</given-names></name><name name-style="western"><surname>Lauber</surname><given-names>CL</given-names></name><name name-style="western"><surname>Knight</surname><given-names>R</given-names></name></person-group>. <article-title>The influence of sex, handedness, and washing on the diversity of hand surface bacteria</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2008</year>) <volume>105</volume>(<issue>46</issue>):<page-range>17994&#8211;9</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1073/pnas.0807920105</pub-id><pub-id pub-id-type="pmcid">PMC2584711</pub-id><pub-id pub-id-type="pmid">19004758</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ying</surname><given-names>S</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>DN</given-names></name><name name-style="western"><surname>Chi</surname><given-names>L</given-names></name><name name-style="western"><surname>Tan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Galzote</surname><given-names>C</given-names></name><name name-style="western"><surname>Cardona</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>The influence of age and gender on skin-associated microbial communities in urban and rural human populations</article-title>. <source>PloS One</source> (<year>2015</year>) <volume>10</volume>(<issue>10</issue>):<elocation-id>e0141842</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1371/journal.pone.0141842</pub-id><pub-id pub-id-type="pmid">26510185</pub-id><pub-id pub-id-type="pmcid">PMC4624872</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ring</surname><given-names>HC</given-names></name><name name-style="western"><surname>Thorsen</surname><given-names>J</given-names></name><name name-style="western"><surname>Saunte</surname><given-names>DM</given-names></name><name name-style="western"><surname>Lilje</surname><given-names>B</given-names></name><name name-style="western"><surname>Bay</surname><given-names>L</given-names></name><name name-style="western"><surname>Riis</surname><given-names>PT</given-names></name><etal/></person-group>. <article-title>The follicular skin microbiome in patients with hidradenitis suppurativa and healthy controls</article-title>. <source>JAMA Dermatol</source> (<year>2017</year>) <volume>153</volume>(<issue>9</issue>):<fpage>897</fpage>&#8211;<lpage>905</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.1001/jamadermatol.2017.0904</pub-id><pub-id pub-id-type="pmid">28538949</pub-id><pub-id pub-id-type="pmcid">PMC5710430</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosi</surname><given-names>E</given-names></name><name name-style="western"><surname>Fastame</surname><given-names>MT</given-names></name><name name-style="western"><surname>Scandagli</surname><given-names>I</given-names></name><name name-style="western"><surname>Di Cesare</surname><given-names>A</given-names></name><name name-style="western"><surname>Ricceri</surname><given-names>F</given-names></name><name name-style="western"><surname>Pimpinelli</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Insights into the pathogenesis of HS and therapeutical approaches</article-title>. <source>Biomedicines</source> (<year>2021</year>) <volume>9</volume>(<issue>9</issue>):<elocation-id>1168</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.3390/biomedicines9091168</pub-id><pub-id pub-id-type="pmid">34572354</pub-id><pub-id pub-id-type="pmcid">PMC8467309</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harder</surname><given-names>J</given-names></name><name name-style="western"><surname>Tsuruta</surname><given-names>D</given-names></name><name name-style="western"><surname>Murakami</surname><given-names>M</given-names></name><name name-style="western"><surname>Kurokawa</surname><given-names>I</given-names></name></person-group>. <article-title>What is the role of antimicrobial peptides (AMP) in acne vulgaris</article-title>? <source>Exp Dermatol</source> (<year>2013</year>) <volume>22</volume>(<issue>6</issue>):<page-range>386&#8211;91</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/exd.12159</pub-id><pub-id pub-id-type="pmid">23711061</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>W-T</given-names></name><name name-style="western"><surname>Chi</surname><given-names>C-C</given-names></name></person-group>. <article-title>Association of hidradenitis suppurativa with inflammatory bowel disease: a systematic review and meta-analysis</article-title>. <source>JAMA Dermatol</source> (<year>2019</year>) <volume>155</volume>(<issue>9</issue>):<page-range>1022&#8211;7</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1001/jamadermatol.2019.0891</pub-id><pub-id pub-id-type="pmcid">PMC6625071</pub-id><pub-id pub-id-type="pmid">31290938</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rustgi</surname><given-names>SD</given-names></name><name name-style="western"><surname>Kayal</surname><given-names>M</given-names></name><name name-style="western"><surname>Shah</surname><given-names>SC</given-names></name></person-group>. <article-title>Sex-based differences in inflammatory bowel diseases: a review</article-title>. <source>Therap Adv Gastroenterol</source> (<year>2020</year>) <volume>13</volume>:<elocation-id>1756284820915043</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1177/1756284820915043</pub-id><pub-id pub-id-type="pmcid">PMC7236567</pub-id><pub-id pub-id-type="pmid">32523620</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olejniczak-Staruch</surname><given-names>I</given-names></name><name name-style="western"><surname>Ci&#261;&#380;y&#324;ska</surname><given-names>M</given-names></name><name name-style="western"><surname>Sobolewska-Sztychny</surname><given-names>D</given-names></name><name name-style="western"><surname>Narbutt</surname><given-names>J</given-names></name><name name-style="western"><surname>Skibi&#324;ska</surname><given-names>M</given-names></name><name name-style="western"><surname>Lesiak</surname><given-names>A</given-names></name></person-group>. <article-title>Alterations of the skin and gut microbiome in psoriasis and psoriatic arthritis</article-title>. <source>Int J Mol Sci</source> (<year>2021</year>) <volume>22</volume>(<issue>8</issue>):<elocation-id>3998</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.3390/ijms22083998</pub-id><pub-id pub-id-type="pmid">33924414</pub-id><pub-id pub-id-type="pmcid">PMC8069836</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wark</surname><given-names>KJL</given-names></name><name name-style="western"><surname>Cains</surname><given-names>GD</given-names></name></person-group>. <article-title>The microbiome in hidradenitis suppurativa: a review</article-title>. <source>Dermatol Ther (Heidelb).</source> (<year>2021</year>) <volume>11</volume>(<issue>1</issue>):<fpage>39</fpage>&#8211;<lpage>52</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s13555-020-00465-w</pub-id><pub-id pub-id-type="pmid">33244661</pub-id><pub-id pub-id-type="pmcid">PMC7859000</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tzellos</surname><given-names>T</given-names></name><name name-style="western"><surname>Zouboulis</surname><given-names>CC</given-names></name><name name-style="western"><surname>Gulliver</surname><given-names>W</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>AD</given-names></name><name name-style="western"><surname>Wolkenstein</surname><given-names>P</given-names></name><name name-style="western"><surname>Jemec</surname><given-names>GBE</given-names></name></person-group>. <article-title>Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies</article-title>. <source>Br J Dermatol</source> (<year>2015</year>) <volume>173</volume>(<issue>5</issue>):<page-range>1142&#8211;55</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/bjd.14024</pub-id><pub-id pub-id-type="pmid">26153913</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ergun</surname><given-names>T</given-names></name></person-group>. <article-title>Hidradenitis suppurativa and the metabolic syndrome</article-title>. <source>Clin Dermatol</source> (<year>2018</year>) <volume>36</volume>(<issue>1</issue>):<page-range>41&#8211;7</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.clindermatol.2017.09.007</pub-id><pub-id pub-id-type="pmid">29241751</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kam</surname><given-names>S</given-names></name><name name-style="western"><surname>Collard</surname><given-names>M</given-names></name><name name-style="western"><surname>Lam</surname><given-names>J</given-names></name><name name-style="western"><surname>Alani</surname><given-names>RM</given-names></name></person-group>. <article-title>Gut microbiome perturbations in patients with hidradenitis suppurativa: a case series</article-title>. <source>J Invest Dermatol</source> (<year>2021</year>) <volume>141</volume>(<issue>1</issue>):<fpage>225</fpage>&#8211;<lpage>228.e2</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.jid.2020.04.017</pub-id><pub-id pub-id-type="pmid">32422215</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>HS</given-names></name><name name-style="western"><surname>Jung</surname><given-names>HM</given-names></name><name name-style="western"><surname>Kim</surname><given-names>GM</given-names></name><name name-style="western"><surname>Bae</surname><given-names>JM</given-names></name></person-group>. <article-title>Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population-based study</article-title>. <source>J Eur Acad Dermatol Venereol.</source> (<year>2018</year>) <volume>32</volume>(<issue>10</issue>):<page-range>1784&#8211;90</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/jdv.15071</pub-id><pub-id pub-id-type="pmid">29761904</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kurokawa</surname><given-names>I</given-names></name><name name-style="western"><surname>Hayashi</surname><given-names>N</given-names></name><collab>Japan Acne Research Society</collab></person-group>. <article-title>Questionnaire surveillance of hidradenitis suppurativa in Japan</article-title>. <source>J Dermatol</source> (<year>2015</year>) <volume>42</volume>(<issue>7</issue>):<page-range>747&#8211;9</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/1346-8138.12881</pub-id><pub-id pub-id-type="pmid">25898994</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>JH</given-names></name><name name-style="western"><surname>Moon</surname><given-names>J</given-names></name><name name-style="western"><surname>Kye</surname><given-names>YC</given-names></name><name name-style="western"><surname>Kim</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Kim</surname><given-names>MN</given-names></name><name name-style="western"><surname>Ro</surname><given-names>YS</given-names></name><etal/></person-group>. <article-title>Demographic and clinical features of hidradenitis suppurativa in Korea</article-title>. <source>J Dermatol</source> (<year>2018</year>) <volume>45</volume>(<issue>12</issue>):<page-range>1389&#8211;95</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1111/1346-8138.14656</pub-id><pub-id pub-id-type="pmid">30294846</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hessam</surname><given-names>S</given-names></name><name name-style="western"><surname>Sand</surname><given-names>M</given-names></name><name name-style="western"><surname>Gambichler</surname><given-names>T</given-names></name><name name-style="western"><surname>Bechara</surname><given-names>FG</given-names></name></person-group>. <article-title>Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS)</article-title>. <source>J Am Acad Dermatol</source> (<year>2015</year>) <volume>73</volume>(<issue>6</issue>):<fpage>998</fpage>&#8211;<lpage>1005</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.jaad.2015.08.052</pub-id><pub-id pub-id-type="pmid">26410359</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dertinger</surname><given-names>SD</given-names></name><name name-style="western"><surname>Silverstone</surname><given-names>AE</given-names></name><name name-style="western"><surname>Gasiewicz</surname><given-names>TA</given-names></name></person-group>. <article-title>Influence of aromatic hydrocarbon receptor-mediated events on the genotoxicity of cigarette smoke condensate</article-title>. <source>Carcinogenesis</source> (<year>1998</year>) <volume>19</volume>(<issue>11</issue>):<page-range>2037&#8211;42</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1093/carcin/19.11.2037</pub-id><pub-id pub-id-type="pmid">9855021</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Napolitano</surname><given-names>M</given-names></name><name name-style="western"><surname>Fabbrocini</surname><given-names>G</given-names></name><name name-style="western"><surname>Martora</surname><given-names>F</given-names></name><name name-style="western"><surname>Picone</surname><given-names>V</given-names></name><name name-style="western"><surname>Morelli</surname><given-names>P</given-names></name><name name-style="western"><surname>Patruno</surname><given-names>C</given-names></name></person-group>. <article-title>Role of aryl hydrocarbon receptor activation in inflammatory chronic skin diseases</article-title>. <source>Cells</source> (<year>2021</year>) <volume>10</volume>(<issue>12</issue>):<elocation-id>3559</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.3390/cells10123559</pub-id><pub-id pub-id-type="pmid">34944067</pub-id><pub-id pub-id-type="pmcid">PMC8700074</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guenin-Mac&#233;</surname><given-names>L</given-names></name><name name-style="western"><surname>Morel</surname><given-names>JD</given-names></name><name name-style="western"><surname>Doisne</surname><given-names>JM</given-names></name><name name-style="western"><surname>Schiavo</surname><given-names>A</given-names></name><name name-style="western"><surname>Boulet</surname><given-names>L</given-names></name><name name-style="western"><surname>Mayau</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Dysregulation of tryptophan catabolism at the host-skin microbiota interface in hidradenitis suppurativa</article-title>. <source>JCI Insight</source> (<year>2020</year>) <volume>5</volume>(<issue>20</issue>):<elocation-id>e140598</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.1172/jci.insight.140598</pub-id><pub-id pub-id-type="pmid">32970636</pub-id><pub-id pub-id-type="pmcid">PMC7605522</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mali&#324;ska</surname><given-names>D</given-names></name><name name-style="western"><surname>Wi&#281;ckowski</surname><given-names>MR</given-names></name><name name-style="western"><surname>Michalska</surname><given-names>B</given-names></name><name name-style="western"><surname>Drabik</surname><given-names>K</given-names></name><name name-style="western"><surname>Prill</surname><given-names>M</given-names></name><name name-style="western"><surname>Patalas-Krawczyk</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Mitochondria as a possible target for nicotine action</article-title>. <source>J Bioenerg Biomembr</source> (<year>2019</year>) <volume>51</volume>(<issue>4</issue>):<page-range>259&#8211;76</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1007/s10863-019-09800-z</pub-id><pub-id pub-id-type="pmcid">PMC6679833</pub-id><pub-id pub-id-type="pmid">31197632</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lim</surname><given-names>SYD</given-names></name><name name-style="western"><surname>Oon</surname><given-names>HH</given-names></name></person-group>. <article-title>Systematic review of immunomodulatory therapies for hidradenitis suppurativa</article-title>. <source>Biologics</source> (<year>2019</year>) <volume>13</volume>:<fpage>53</fpage>&#8211;<lpage>78</lpage>. doi:&#160;<pub-id pub-id-type="doi">10.2147/BTT.S199862</pub-id><pub-id pub-id-type="pmid">31190730</pub-id><pub-id pub-id-type="pmcid">PMC6526329</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kimball</surname><given-names>AB</given-names></name><name name-style="western"><surname>Okun</surname><given-names>MM</given-names></name><name name-style="western"><surname>Williams</surname><given-names>DA</given-names></name><name name-style="western"><surname>Gottlieb</surname><given-names>AB</given-names></name><name name-style="western"><surname>Papp</surname><given-names>KA</given-names></name><name name-style="western"><surname>Zouboulis</surname><given-names>CC</given-names></name><etal/></person-group>. <article-title>Two phase 3 trials of adalimumab for hidradenitis suppurativa</article-title>. <source>N Engl J Med</source> (<year>2016</year>) <volume>375</volume>(<issue>5</issue>):<page-range>422&#8211;34</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1056/NEJMoa1504370</pub-id><pub-id pub-id-type="pmid">27518661</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gau</surname><given-names>SY</given-names></name><name name-style="western"><surname>Preclaro</surname><given-names>IAC</given-names></name><name name-style="western"><surname>Wei</surname><given-names>JC</given-names></name><name name-style="western"><surname>Lee</surname><given-names>CY</given-names></name><name name-style="western"><surname>Kuan</surname><given-names>YH</given-names></name><name name-style="western"><surname>Hsiao</surname><given-names>YP</given-names></name><etal/></person-group>. <article-title>Risk of psoriasis in people with hidradenitis suppurativa: a systematic review and meta-analysis</article-title>. <source>Front Immunol</source> (<year>2022</year>) <volume>13</volume>:<elocation-id>103384</elocation-id>. doi:&#160;<pub-id pub-id-type="doi">10.3389/fimmu.2022.103384</pub-id><pub-id pub-id-type="pmcid">PMC9752046</pub-id><pub-id pub-id-type="pmid">36532043</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>